“…ESCs [222], iPSCs [43,223], NSCs/NPCs [224,225], MSCs [180,181], OPCs [226], DPSCs [216] and ADSCs [227] Olfactory ensheathing cells [228] and Schwann cells [229] Microglia [230] Directly reprogrammed NPCs (drNPCs) [231][232][233] Gene therapies Nucleic acid-based therapies Delivery methods Other siRNA to AQP-4 [234], nNOS [235], iNOS [236], IL-6 [237], claudin-5 [238], RhoA [239,240], PLK-4 [241], PTEN [242,243], Sema3A [244], CTGF [245], combinatorial [246] and in combination with MSCs [242] Nanoparticle-coated siRNA [247][248][249], polymer nanocarriers [239], exosome delivery [243,245] extracellular vesicles [250], intrathecal delivery [240], photomechanical wave [251] and intranasal delivery [242] Chemogenetic stimulation [252]…”